ORPH
Income statement / Annual
Last year (2023), Orphazyme A/S's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Orphazyme A/S's net income was -$26.05 M.
See Orphazyme A/S,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$36.19 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$782.00 K
|
$18.11 M
|
$5.20 M
|
$3.80 M
|
$1.37 M
|
$746.00 K
|
$572.00 K
|
$0.00
|
| Gross Profit |
$0.00
|
-$782.00 K
|
$18.08 M
|
-$5.20 M
|
-$3.80 M
|
-$1.37 M
|
-$746.00 K
|
-$572.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0.5
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$229.94 M
|
$261.14 M
|
$285.41 M
|
$154.95 M
|
$99.05 M
|
$55.82 M
|
$45.87 M
|
| General & Administrative Expenses |
$12.88 K
|
$41.24 K
|
$421.44 M
|
$342.20 M
|
$49.84 M
|
$75.33 M
|
$31.99 M
|
$7.70 M
|
$7.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$39.38 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.88 K
|
$40.46 M
|
$421.44 M
|
$342.20 M
|
$49.84 M
|
$75.33 M
|
$31.99 M
|
$7.70 M
|
$7.22 M
|
| Other Expenses |
$14.16 K
|
$0.00
|
$18.11 M
|
$5.20 M
|
$699.00 K
|
$1.37 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$27.04 K
|
$40.46 M
|
$669.50 M
|
$608.53 M
|
$335.95 M
|
$231.65 M
|
$131.04 M
|
$63.52 M
|
$53.09 M
|
| Cost And Expenses |
$27.04 K
|
$41.24 M
|
$669.50 M
|
$608.53 M
|
$335.95 M
|
$231.65 M
|
$131.04 M
|
$63.52 M
|
$53.09 M
|
| Interest Income |
$786.00 K
|
$193.00 K
|
$37.00 K
|
$45.00 K
|
$316.00 K
|
$5.00 K
|
$0.00
|
$2.00 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$9.46 M
|
$14.11 M
|
$4.80 M
|
$3.45 M
|
$647.00 K
|
$71.00 K
|
$40.00
|
| Depreciation & Amortization |
$782.00
|
$782.00 K
|
$18.11 M
|
$5.20 M
|
$3.80 M
|
$1.37 M
|
$746.00 K
|
$572.00 K
|
$554.00 K
|
| EBITDA |
-$26.05 M |
-$40.46 M |
-$603.91 M |
-$615.70 M |
-$334.31 M |
-$230.28 M |
-$130.27 M |
-$62.95 M |
-$58.47 M |
| EBITDA Ratio |
0
|
0
|
-16.69
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
-17.5
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$993.00 K
|
$185.00 K
|
$549.87 M
|
-$26.63 M
|
-$7.04 M
|
-$3.45 M
|
-$662.00 K
|
$85.00 K
|
-$5.88 M
|
| Income Before Tax |
-$26.05 K
|
-$41.06 M
|
-$631.48 M
|
-$635.16 M
|
-$343.00 M
|
-$235.10 M
|
-$131.70 M
|
-$63.44 M
|
-$53.40 M
|
| Income Before Tax Ratio |
0
|
0
|
-17.45
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$782.00
|
-$2.75 M
|
-$4.94 M
|
-$1.92 M
|
-$5.50 M
|
-$5.50 M
|
-$5.50 M
|
-$5.50 M
|
-$5.69 M
|
| Net Income |
-$26.05 M
|
-$110.59 M
|
-$626.54 M
|
-$633.25 M
|
-$337.50 M
|
-$229.60 M
|
-$126.20 M
|
-$57.94 M
|
-$47.71 M
|
| Net Income Ratio |
0
|
0
|
-17.31
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.74 |
-3.14 |
-17.94 |
-22.32 |
-16.87 |
-11.47 |
-10.43 |
-5.89 |
-4.66 |
| EPS Diluted |
-0.74 |
-3.14 |
-17.94 |
-22.32 |
-16.87 |
-11.47 |
-10.43 |
-5.65 |
-4.66 |
| Weighted Average Shares Out |
$35.00 M
|
$35.27 M
|
$34.92 M
|
$28.37 M
|
$20.00 M
|
$20.01 M
|
$12.10 M
|
$9.83 M
|
$10.25 M
|
| Weighted Average Shares Out Diluted |
$35.31 M
|
$35.27 M
|
$34.92 M
|
$28.37 M
|
$20.00 M
|
$20.01 M
|
$12.10 M
|
$10.25 M
|
$10.25 M
|
| Link |
|
|
|
|
|
|
|
|
|
